Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatkin Jones Regulatory News (WJG)

Share Price Information for Watkin Jones (WJG)

Share Price is delayed by 15 minutes
Get Live Data
19.34    0.84 (4.54%)
Bid:
19.34
Ask:
20.45
Spread: 1.11 (5.739%)
Market Cap: £49.68m
WJG Live PriceLast checked at - London Stock Exchange

Intraday Watkin Jones Share Chart

Planning consent for BTR development

14 Aug 2017 07:00

RNS Number : 8346N
Watkin Jones plc
14 August 2017
 

For immediate release

14 August 2017

 

 

Watkin Jones plc

('Watkin Jones' or the 'Group')

 

Planning consent for BTR development

 

Watkin Jones plc (AIM:WJG), a leading UK developer and constructor of multi occupancy property assets, with a focus on the student accommodation and Build to Rent sectors, is pleased to announce that the Group has secured planning consent for a further Build to Rent ('BTR') development at Bath Lane in Leicester.

 

The significant 322 unit site will consist of 174 one bed units, 137 two bed units and 11 three bed units. The Group expects to commence work on the site in FY 2018 with a phased completion anticipated during FY 2019 - FY 2020.

 

As reported on the 1 June, the BTR pipeline continues to grow and there are now six schemes currently targeted for delivery over the period FY 2019 - 2021, with a number of planning applications and other site acquisition opportunities in negotiation.

 

Mark Watkin Jones, Chief Executive Officer of Watkin Jones plc, said: "We are delighted to announce the further progression of our BTR business. Our plan to sustainably grow this exciting element of the Group continues and we are pleased to see that opportunities from within the development pipeline are moving forward. We believe the BTR business will continue to drive growth, alongside our student accommodation business, as well as providing excellent visibility of earnings and cash flow."

 

- Ends -

 

For further information:

Watkin Jones plc

 

Mark Watkin Jones, Chief Executive Officer

Tel: +44 (0) 1248 362 516

Phil Byrom, Chief Financial Officer

www.watkinjonesplc.com

 

 

Peel Hunt LLP (Nominated Adviser & Joint Corporate Broker)

 Tel: +44 (0) 20 7418 8900

Mike Bell / Justin Jones / Matthew Brooke-Hitching

www.peelhunt.com

 

 

Jefferies Hoare Govett (Joint Corporate Broker)

Tel: +44 (0) 20 7029 8000

Max Jones / Will Soutar

www.jefferies.com

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Richard Oldworth

Jamie Hooper / Steph Watson

 

Tel: +44 (0) 20 7466 5000

watkinjones@buchanan.uk.com

www.buchanan.uk.com

 

 

Notes to Editors

 

Watkin Jones is a leading UK developer and constructor of multi occupancy property assets, with a focus on the student accommodation sector. The Group has strong relationships with institutional investors, and a good reputation for successful, on-time-delivery of high quality developments. Since 1999, Watkin Jones has delivered over 31,800 student beds across 98 sites, making it a key player and leader in the UK purpose built student accommodation market. In addition, Watkin Jones has been responsible for over 50 residential developments, ranging from starter homes to executive housing and apartments.

 

The Group's competitive advantage lies in its experienced management team and business model, which enables it to offer an end-to-end solution for investors, delivered entirely in-house with minimal reliance on third parties, across the entire life cycle of an asset. 

 

Watkin Jones was admitted to trading on AIM in March 2016 with the ticker WJG.L. For additional information please visit: www.watkinjonesplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKDDNPBKDCFD
Date   Source Headline
23rd Jan 20257:00 amRNSFull Year Results 2024
17th Jan 20257:00 amRNSNotice of Results
2nd Dec 20247:00 amRNSDevelopment Partnership for 295 homes in St Helens
30th Aug 20243:15 pmRNSDirector/PDMR Shareholding
22nd Aug 20241:09 pmRNSDirector Shareholding
21st Aug 20247:00 amRNSFY24 Trading Update
29th Jul 20247:00 amRNSMajor PBSA development funded with HGP
12th Jul 20246:05 pmRNSNotification of Major Holdings
2nd Jul 202410:23 amRNSIssue of Sharesave options and PDMR shareholding
21st May 20248:05 amRNSProgressive publishes new research
21st May 20247:00 amRNSHalf Year Results
2nd May 20247:00 amRNSPresentation via Investor Meet Company
23rd Apr 20247:00 amRNSAppointment of CFO
23rd Apr 20247:00 amRNSHY24 Trading Update
15th Mar 20243:42 pmRNSDirector/PDMR Shareholding
7th Mar 20244:05 pmRNSForward Sale of PBSA Development in Bristol
29th Feb 20245:17 pmRNSResult of AGM
9th Feb 20243:30 pmRNSNotification of Major Holdings
1st Feb 20242:15 pmRNSAnnual Report and Notice of AGM
31st Jan 20241:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSFull Year Results 2023
18th Jan 20247:00 amRNSPresentation via Investor Meet Company
10th Jan 20247:00 amRNSNotice of Final Results
14th Dec 20237:00 amRNSChange of Registered Office
16th Nov 20236:20 pmRNSNotification of Major Holdings
15th Nov 20237:00 amRNSAppointment of Chief Executive Officer
24th Oct 20233:46 pmRNSNotification of Major Holdings
19th Oct 202312:43 pmRNSNotification of Major Holdings
12th Oct 20232:24 pmRNSDirector Shareholding
11th Oct 20231:16 pmRNSDirector Shareholding
11th Oct 20237:00 amRNSFY23 Trading Update
3rd Oct 20234:23 pmRNSNotification of Major Holdings
3rd Oct 20234:18 pmRNSCorrection: Notification of Major Holdings
1st Sep 20238:00 amRNSNotification of Major Holdings
17th Aug 20237:00 amRNSSale of three non-core PRS operational assets
19th Jul 20232:52 pmRNSDirector Shareholding
19th Jul 20237:00 amRNSBoard Change
19th Jul 20237:00 amRNSTrading Update
22nd Jun 20233:53 pmRNSNotification of Major Holdings
5th Jun 20237:00 amRNSSuccessful £155m forward sale with L&G and Clanmil
24th May 20237:00 amRNSDirector Shareholding
23rd May 20237:10 amRNSHalf Year Results
15th May 202310:45 amRNSIssue of Equity
13th Apr 20237:00 amRNSH1-2023 Trading Update
28th Feb 20234:00 pmRNSResults of AGM
17th Feb 20237:00 amRNSDirector/PDMR Shareholding
14th Feb 20233:31 pmRNSDirector Shareholding
8th Feb 20237:00 amRNSPresentation via Investor Meet Company
6th Feb 20237:00 amRNSDirector/PDMR Shareholding
2nd Feb 202312:30 pmRNSAnnual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.